The Pharmacy Times® Gastrointestinal resource center provides news and articles centered around the FDA approved drugs in gastroenterology, as well as links to condition-specific resources, and videos and other content.
What can we help you find?
The researchers analyzed the National Health Interview Survey 2015 to determine the food intake and frequency of consumption for US adults with IBD.
In a new study, researchers analyzed gut microbiota to understand further the links between gut health and obesity.
Why was a patient prescribed something normally used for stomach problems to help her produce breastmilk?
Generic products featured in the April 2020 issue.
A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.
The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.
What are you going to recommend for a customer who was unable to complete a previously recommended regimen?
In a series of studies, researchers described the identification of predictive tools and a new understanding of environmental factors that trigger inflammatory bowel disease.
The goal of therapy centers on improving quality of life, maintaining remission, and preventing hospitalization and surgery.
How can this patient better tolerate polyethylene glycol (PEG)-electrolyte lavage solution?
Pre-Measured Omeprazole Suspension Kit Offers More Stability, Longer Duration Than Traditional Suspension
FIRST Omeprazole Kits offer a pre-measured option for pharmacists dispensing suspended Omeprazole.
Tofacitinib, currently used to treat rheumatoid arthritis and ulcerative colitis, has a correcting effect on defects that occur in inflammation.